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Background and Purpose—The location of the thrombus as observed on first digital subtraction angiography during 
endovascular treatment may differ from the initial observation on initial noninvasive imaging. We studied the incidence 
of thrombus dynamics, its impact on patient outcomes, and its association with intravenous thrombolytics.
Methods—We included patients from the MR CLEAN registry (Multicenter Randomized Clinical Trial of Endovascular 
Treatment of Acute Ischemic Stroke) with an initial target occlusion on computed tomography angiography located in 
the intracranial internal carotid artery, M1, or M2. The conventional angiography target occlusion was defined during 
endovascular treatment. Thrombus dynamics were classified as growth, stability, migration, and resolution. The primary 
outcome was functional outcome at 90 days (modified Rankin Scale). The secondary outcomes were successful and 
complete reperfusion (extended treatment in cerebral infarction scores of 2b-3 and 3, respectively).
Results—The analysis included 1349 patients. Thrombus migration occurred in 302 (22%) patients, thrombus growth in 
87 (6%), and thrombus resolution in 39 (3%). Intravenous treatment with alteplase was associated with more thrombus 
migration (adjusted odds ratio, 2.01; CI, 1.29–3.11) and thrombus resolution (adjusted odds ratio, 1.85; CI, 1.22–2.80). 
Thrombus migration was associated with a lower chance of complete reperfusion (adjusted odds ratio, 0.57; CI, 0.42–
0.78) and successful reperfusion (adjusted odds ratio, 0.74; CI, 0.55–0.99). In the subgroup of patients with M1 initial 
target occlusion, thrombus migration was associated with better functional outcome (adjusted common odds ratio, 1.49; 
CI, 1.02–2.17), and there was a trend towards better functional outcome in patients with thrombus resolution (adjusted 
common odds ratio, 2.23; CI, 0.93–5.37).
Conclusions—In patients with acute ischemic stroke, thrombus location regularly changes between computed tomography 
angiography and digital subtraction angiography. Administration of intravenous alteplase increases the chance of 
thrombus migration and resolution. Thrombus migration is associated with better functional outcome but reduces the rate 
of complete reperfusion.   (Stroke. 2019;50:3156-3163. DOI: 10.1161/STROKEAHA.119.026107.)
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Multiple randomized clinical trials demonstrated the ben-efit of endovascular treatment (EVT) for patients with 
an acute ischemic stroke caused by a large-vessel occlusion.1,2 
Thrombus location is a vital imaging selection criterion be-
cause the benefit of EVT for distal occlusions, especially M2, 
remains uncertain.3–6 In the current workflow of acute ischemic 
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stroke, thrombus location is determined at 2 moments: the in-
itial target occlusion is determined on noninvasive imaging, 
usually by computed tomography angiography (CTA) at in-
itial presentation. If a large-vessel occlusion is detected, the 
patient is considered for EVT. During this procedure, conven-
tional angiography is performed, which allows the determina-
tion of the conventional angiography target occlusion.7
Despite recent progress, there is still a paucity of infor-
mation about thrombus imaging on patients with stroke with 
large-vessel occlusion.8,9 Thrombus dynamics (a difference 
between the initial and the conventional angiography target 
occlusions) have been described in few studies and reported 
anecdotally.10–12 Distal thrombus migration has been defined 
as a more distal conventional angiography target occlusion 
than the initial target occlusion.13 In patients with EVT, distal 
thrombus migration increased the risk of incomplete reper-
fusion, suggesting thrombus fragility.13 Thrombus resolution 
has also been detailed, especially after intravenous admin-
istration of alteplase (IVT).14–16 Moreover, thrombus growth 
has also been studied, and it has been associated with poor 
collaterals, blood stasis, and early neurological deterioration, 
suggesting that thrombus dynamics is related to thrombus 
composition.17,18 Despite these previously reported stud-
ies, the impact of thrombus migration on patient outcomes 
and the association between IVT and thrombus dynamics is 
undetermined.13,19,20
The aim of this study is to determine the association 
of thrombus dynamics with IVT and its effect on patient 
outcome.
Methods
We included patients from the MR CLEAN registry (Multicenter 
Randomized Clinical Trial of Endovascular Treatment of Acute 
Ischemic Stroke), an observational, prospective study, registering 
patients who underwent EVT (defined as receiving arterial puncture 
for angiography) for acute ischemic stroke in 16 intervention centers 
in the Netherlands from 2014 to 2016.21 Patients with anterior and 
posterior circulation stroke were included. Neither Alberta Stroke 
Program Early CT Score nor collateral grade was an explicit exclu-
sion criterion. The registry was approved by a central medical eth-
ics committee and by the research board of all participating centers. 
Source data of this study are available from the corresponding author 
on reasonable request.
Initial target occlusion was defined as the most proximal thrombus 
location on CTA.12 Conventional angiography target occlusion was 
defined as the most proximal thrombus location on first intracranial 
digital subtraction angiography. Target occlusion locations were de-
termined by a core lab. Thrombus location was classified as cervical 
internal carotid artery (ICA), intracranial ICA, M1, M2, M3, M4, A1, 
A2, or no occlusions. In the current analysis, patients with an initial 
target occlusion of the intracranial ICA or the first and second seg-
ments of the middle cerebral artery (M1 and M2) were included.
Thrombus dynamics were classified as migration, growth, or res-
olution. Thrombus migration was defined as a shift to a more distal 
conventional angiography target occlusion than the initial target 
occlusion. Thrombus growth was defined as a shift to a more prox-
imal conventional angiography target occlusion thrombus location 
than the initial target occlusion. Thrombus resolution was defined as 
the absence of conventional angiography target occlusion.
Statistical Analysis
Baseline, workflow, treatment, and outcome characteristics 
were compared between patients with stable thrombus and 
different types of thrombus dynamics. Group comparisons 
were performed using Student t, Kruskal-Wallis, and χ2 tests. 
Binary regression models were used to assess whether IVT 
was associated with migration, growth, or resolution com-
pared with stable thrombus. The primary outcome was func-
tional outcome, expressed with the score on the modified 
Rankin Scale at 3 months. On this scale, a score of 0 corre-
sponds to no symptoms and a score of 6 to death. The associa-
tion between thrombus dynamics and functional outcome was 
expressed as a common odds ratio (cOR) for a shift towards 
a better functional outcome estimated with ordinal regression. 
The secondary outcome was reperfusion status (successful or 
complete reperfusion). Reperfusion was assessed on digital 
subtraction angiography using the expanded Thrombolysis 
in Cerebral Infarction (eTICI) score. Successful reperfusion 
was defined as an eTICI score of 2b, 2c, or 3.22 Complete re-
perfusion was defined as an eTICI score of 3.23 The associ-
ation of different thrombus dynamics and reperfusion status 
was assessed using binary regression. The associations be-
tween different types of thrombus dynamics and primary and 
secondary outcomes as well as the associations between IVT 
and thrombus dynamics were assessed by univariable and 
multivariable models. The multivariable IVT models were 
adjusted for age, history of atrial fibrillation, history of pe-
ripheral artery disease, collateral score, serum glucose level, 
history of diabetes mellitus, arterial blood pressure, (interna-
tional normalized ratio >1.7), time from onset to computed to-
mography, previous stroke and novel anticoagulants use. The 
multivariable outcome models (modified Rankin Scale and 
reperfusion status) were adjusted for age, baseline National 
Institutes of Health Stroke Scale, IVT treatment, prestroke 
modified Rankin Scale, time from onset to groin puncture, 
history of atrial fibrillation, symptomatic cervical carotid ob-
struction on CTA, and collateral grade. To reduce the influence 
of thrombus location on patient outcome, we also assessed 
the effect of the thrombus growth, migration, and resolution 
on primary and secondary outcomes including only patients 
with M1 initial target occlusion. On multivariable models, the 
associations were expressed as adjusted cOR for ordinal re-
gression and adjusted odds ratio (aOR) for binary regressions. 
For the regression models, we performed multiple imputations 
for the missing data. All reported data were not imputed. The 
statistical analysis was performed using R (R Foundation for 
Statistical Computing, Vienna, Austria; version 1.0.136).
Table 1. Conventional Angiography Target Occlusion Location Stratified by the 
Initial Target Occlusion Location
Target 
Occlusion Conventional Angiography
Initial
Intracranial 
ICA M1 M2 M3 M4 None Total
Intracranial 
ICA
215 121 24 1 2 6 369
M1 45 603 108 22 7 22 807
M2 2 40 103 11 6 11 173
Total 262 764 235 34 15 39 1349
ICA indicates internal carotid artery.
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Table 2. Baseline Characteristics
Thrombus Migration Thrombus Resolution Thrombus Growth Stable Thrombus P Value
n 302 39 87 921  
Age, median, IQR 70 (58–80) 70 (63–80) 69 (58–79) 71 (60–79) 0.77
Sex, male (%) 165 (55%) 32 (82%) 47 (54%) 476 (52%) 0.01
NIHSS, median (IQR) 16 (11–19) 15 (9–19) 16 (11–19) 16 (12–20) 0.46
SBP, mm Hg, mean (SD) 150 (131–166) 151 (132–163) 145 (130–160) 150 (131–167) 0.65
DBP, mm Hg, mean (SD) 80 (70–91) 80 (75–95) 80 (70–90) 80 (70–90) 0.75
Atrial fibrillation, n (%) 53/299(18%) 4/38 (11%) 21/86 (24%) 221/907 (24%) 0.02
Diabetes mellitus, n (%) 50/301 (17%) 10/39 (26%) 11/87 (13%) 151/915 (17%) 0.34
Hypertension, n (%) 149/300 (50%) 16/39 (41%) 44/87 (51%) 468/905 (51%) 0.67
Ischemic stroke, n (%) 44/300 (15%) 3/39 (8%) 14/87 (16%) 152/916 (17%) 0.51
Myocardial infarction, n (%) 44/298 (15%) 8/38 (21%) 13/87 (15%) 141/899 (16%) 0.76
Peripheral artery disease, n (%) 37/298 (12%) 3/39 (8%) 8/86 (9%) 75/902 (8%) 0.21
Prestroke mRS, n (%) 0.92
  0 201/300 (67%) 28/39 (72%) 58/86 (67%) 618/904 (68%)  
  1 36/300 (12%) 2/39 (5%) 12/86 (14%) 120/904 (13%)  
  2 25/300 (8%) 3/39 (8%) 6/86 (7%) 68/904 (8%)  
  ≥3 38/300 (13%) 6/39 (15%) 10/86 (12%) 98/904 (11%)  
Medication
  DOAC, n (%) 5/299 (2%) 0/38 (0%) 2/84 (2%) 27/906 (3%) 0.61
  Vitamin K antagonist, n (%) 30/301 (10%) 2/39 (5%) 10/86 (12%) 128/913 (14%) 0.15
  Antiplatelet use, n (%) 106/299 (36%) 13/39 (33%) 29/87 (33%) 296/909 (33%) 0.83
Imaging
  Occlusion level on DSA, n (%) <0.01
   Intracranial ICA 0/302 (0%) NA 47/87 (54%) 215/921 (23%)
   M1 121/302 (40%) NA 40/87 (46%) 603/921 (66%)
   M2 132/302 (44%) NA 0/87 (0%) 103/921 (11%)
   M3 34/302 (11%) NA 0/87 (0%) 0/921 (0%)
   M4 15/302 (5%) NA 0/87 (0%) 0/921 (0%)
  Other, non target lesion on DSA, n (%) 41/271 (15%) 1/35 (3%) 4/74(5%) 60/828 (7%) <0.01
  Occlusion level on CTA, n (%) <0.01
   Intracranial ICA 148/302 (49%) 6/39 (15%) 0/87 (0%) 215/921 (23%)
   M1 137/302 (45%) 22/39 (56%) 45/87 (52%) 603/921 (66%)
   M2 17/302 (6%) 11/39 (28%) 42/87 (48%) 103/921 (11%)
  Symptomatic cervical ICA obstruction on CTA, n (%) 101/250 (40%) 9/32 (28%) 18/75 (24%) 149/810 (18%) <0.01
  Carotid bifurcation atherosclerosis  
   >50% stenosis, n (%) 32/250 (13%) 3/32 (9%) 8/75 (11%) 70/810 (9%) 0.26
   <50% stenosis, n (%) 91/250 (36%) 13/32 (41%) 26/75 (35%) 393/ 810 (49%) <0.01
  Symptomatic cervical ICA occlusion on CTA, n (%) 49/250 (20%) 3/32 (9%) 7/75 (9%) 56/810 (7%) <0.01
  Intracranial atherosclerosis, n (%) 175/293 (60%) 21/38 (55%) 48/85 (57%) 541/905 (60%) 0.88
  Collateral, n (%) 0.62
   Absent 22/292 (8%) 3/39 (8%) 4/84 (5%) 65/902 (7%)
   <50% of occluded area 107/292 (37%) 11/39 (28%) 23/84 (27%) 287/902 (32%)
   50% to 100% occluded area 111/292 (38%) 15/39 (39%) 34/84 (41%) 350/902 (39%)
(Continued )
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Results
A total of 1627 patients were included in the MR CLEAN 
Registry in our study period. Available data concerning out-
come and baseline characteristics were reported for the 1349 
patients with full data available concerning thrombus charac-
teristics (Figure I in the online-only Data Supplement).
Thrombus migration was observed in 302/1349 (22%), 
thrombus growth in 87/1349 (6%) and thrombus resolution in 
39/1349 (3%) patients. The most common change in occlu-
sion location was ICA to M1 (121; 8%) followed by M1 to M2 
(108; 7%). Thrombus migration occurred in 154/269 (42%) of 
ICA occlusions. Thrombus growth, resolution, or migration 
was also observed in 70/173 (40%) of patients with M2 occlu-
sions (Table 1).
Most baseline characteristics were similar for the groups 
(Table 2). The Clot Burden Score24 was significantly higher in 
patients with thrombus growth and resolution. The frequency 
of atrial fibrillation was lower in patients with thrombus mi-
gration and resolution. Patients with thrombus migration had 
a higher rate of multiple intracranial occlusions detected on 
digital subtraction angiography and of symptomatic cervical 
ICA occlusion on CTA. The rate of transfer from the referral 
center and other time metrics were not significantly different 
among the groups (Table 3).
Symptomatic cervical ICA obstruction (ie, atheroscle-
rosis, dissection, carotid web, and previous stent), atheroscle-
rotic cervical ICA occlusion and treatment (stent and balloon 
angioplasty) were significantly more frequent in patients with 
thrombus migration and resolution (P<0.01). We also found a 
trend towards higher frequency of significant atherosclerotic 
carotid stenosis (>50%) on patients with thrombus migration, 
but it did not reach statistical significance. Patients with stable 
thrombus had a significant higher incidence of nonsignificant 
atherosclerotic carotid stenosis (P<0.01).
IVT was significantly associated with thrombus migration 
and resolution. In patients with IVT, the rate of thrombus mi-
gration was 25% in contrast to a 14% rate in patients without 
IVT. Occurrence of thrombus growth was not significantly as-
sociated with IVT (Table 4).
Compared with patients who had a stable thrombus, 
patients with thrombus migration had better functional out-
comes (Figure II in the online-only Data Supplement). In 
patients with M1 initial target occlusion, thrombus migration 
was associated with better functional outcome (adjusted cOR, 
1.49; CI 95%, 1.02–2.17). Thrombus resolution patients also 
had better functional outcomes; however, statistical signifi-
cance was not reached (adjusted cOR, 2.23; CI 95%, 0.93–
5.37). Thrombus growth was not significantly associated with 
functional outcome. There was a trend towards a better func-
tional outcome (adjusted cOR, 1.18; CI 95%, 0.77–1.81), but 
the association was in the opposite direction when including 
only M1 initial target occlusion (Table 5).
Thrombus migration was associated with worse reperfu-
sion status. (Table 6) Patients with thrombus migration had 
a lower chance of complete reperfusion (aOR, 0.51; CI 95%, 
0.36–0.73) and successful reperfusion (aOR, 0.74; CI 95%, 
0.55–0.99). These findings were similar when including only 
M1 initial target occlusion. By definition, all patients in the 
thrombus resolution group had complete recanalization, but 
5/39 (14%) did not achieve complete reperfusion. Thrombus 
resolution significantly increased the rates of successful reper-
fusion (aOR, 4.17; CI 95%, 1.44–12.1) and complete reperfu-
sion (aOR, 14.5; CI 95%, 5.00–42.1). Thrombus growth was 
not significantly associated with reperfusion status.
   100% occluded area 52/292 (18%) 10/39 (26%) 23/84 (27%) 200/902 (22%)
  ASPECTS, median (IQR) 9 (7–10) 9 (8–10) 9 (7–10) 9 (7–10) 0.67
  Clot burden score, median (IQR) 6 (3–7) 8 (5–9) 8 (5–9) 6 (4–8) <0.01
Workflow
  Transferred from primary stroke center, n (%) 151/302 (50%) 18/39 (46%) 45/87 (52%) 504/921 (55%) 0.39
  Intravenous thrombolysis, n (%) 256/301 (85%) 33/39 (85%) 64/87 (74%) 679/919 (74%) <0.01
  Performed procedure, n (%) <0.01
  Catheterization only 6/302 (2%) 0/39 (0%) 2/87 (2%) 18/921 (2%)
  DSA only 50/302 (17%) 30/39 (77%) 1/87 (1%) 19/921 (2%)
  Mechanical thrombectomy 242/302 (80%) 8/39 (21%) 84/87 (97%) 883/921 (96%)
  Other 4/302 (1%) 1/39 (3%) 0/87 (2%) 1/921 (0%)
  Cervical ICA stent placement, n% 39/294 (13%) 4/39 (10%) 8/83 (10%) 46/889 (5%) <0.01
  Balloon angioplasty, n (%) 29/281 (10%) 3/39 (8%) 3/81 (4%) 37/879 (4%) <0.01
  Onset to groin puncture time, median (IQR) in 
minutes
200 (155–264) 205 (158–236) 225 (174–290) 210 (160–270) 0.20
  Onset to IVT time, median (IQR) in minutes 25 (18–33) 20 (16–27) 25 (20–30) 24 (18–33) 0.24
Group comparisons were evaluated using χ2, Kruskal-Wallis, and Student t tests. ASPECTS indicates Alberta Stroke Program Early CT Score; CTA, computed 
tomography angiography; DBP, diastolic blood pressure; DOAC, use of direct oral anticoagulants; DSA, digital subtraction angiography; ICA, internal carotid artery; IQR, 
interquartile range; IVT, intravenous thrombolysis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and SBP, systolic blood pressure.
Table 2. Continued
Thrombus Migration Thrombus Resolution Thrombus Growth Stable Thrombus P Value
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Discussion
We demonstrated that preinterventional changes in thrombus 
location are common in acute ischemic stroke. In our study, 
thrombus migration was the most common change and was 
associated with improved functional outcome. Interestingly, 
it was also associated with worse reperfusion status. IVT 
increased the rates of thrombus migration and resolution.
The incidence of thrombus migration and growth in our 
study were similar to the incidence documented by other 
studies.13,16,19,20 However, this study showed a lower inci-
dence of thrombus resolution, which may be the result of a 
difference in definition; we defined thrombus resolution as 
complete recanalization before the intervention.16,25 While 
the association of IVT and changes in thrombus location has 
been demonstrated,20 especially in patients with preinter-
ventional reperfusion,25,26 the association was not present in 
other thrombus migration studies.13,16 Our study found that in 
patients treated with IVT, both thrombus migration and res-
olution were more frequent. To the best of our knowledge, 
our study is the first to demonstrate a significantly higher fre-
quency of cervical carotid stenosis in patients with thrombus 
migration. Further, the association between thrombus migra-
tion and better functional outcome was only significant in our 
study.19 This might be due to the different methodology used 
to define migration. Kaesmacher et al13 included patients with 
both direct (angiographic) and indirect evidence of thrombus 
migration by evaluating perfusion deficits within the lenticu-
lostriate artery territory.26 In our study, only direct evidence 
Table 3. Patient Outcome
Thrombus Migration Thrombus Resolution
Thrombus 
Growth Stable Thrombus P Value
n 302 39 87 921  
Follow-up NIHSS (24 h), median (IQR) 10 (3–17) 6 (3–13) 8 (4–15) 11 (4–18) 0.03
Onset to recanalization time, median (IQR) in minutes 256 (209–328) 231 (185–297) 285 (218–342) 271 (222–325) 0.04
Procedure time, median (IQR) in minutes 65 (40–95) 30 (15–58) 62 (45–90) 65 (41–90) <0.01
mRs, n (%) 0.07
  0 21/281 (8%) 5/38 (13%) 6/77 (8%) 42/839 (5%)
  1 43/281 (15%) 8/38 (21%) 15/77 (20%) 97/839 (12%)
  2 59/281 (21%) 6/38 (16%) 9/77 (12%) 177/839 (21%)
  3 46/281 (16%) 2/38 (5%) 12/77 (16%) 120/839 (14%)
  4 36/281 (13%) 5/38 (13%) 10/77 (13%) 116/839 (14%)
  5 10/281 (4%) 4/38 (11%) 6/77 (8%) 44/839 (5%)
  6 66/281 (23%) 8/38 (21%) 19/77 (25%) 243/839 (29%)
eTICI, n (%) <0.01
  0 47/295 (16%) 3/38 (8%) 14/87 (16%) 126/915 (14%)
  1 8/295 (3%) 0/38 (0%) 4/87 (5%) 35/915 (4%)
  2A 77/295 (26%) 1/38 (3%) 19/87 (22%) 201/915 (22%)
  2B 71/295 (24%) 1/38 (3%) 20/87 (23%) 167/915 (18%)
  2C 29/295 (10%) 0/38 (0%) 7/87 (8%) 94/915 (10%)
  3 63/295 (21%) 33/38 (87%) 23/87 (26%) 292/915 (32%)
Symptomatic intracranial hemorrhage, n (%) 18/302 (6%) 3/39 (8%) 4/87 (5%) 56/921 (6%) 0.90
Stroke progression to clinical deterioration or death, n (%) 26/302 (9%) 2/39 (5%) 13/87 (15%) 83/921 (9%) 0.26
eTICI indicates expanded treatment in cerebral infarction score; IQR, interquartile range; mRS, modified Rankin Scale; and NIHSS, National Institutes of Health 
Stroke Scale.
Table 4. Associations Between the Administration of Intravenous Thrombolytics and Changes in Occlusion Location
Thrombus Resolution Thrombus Migration Thrombus Growth
Univariate Multivariable* Univariate Multivariable* Univariate Multivariable*
Intravenous 
thrombolytics—OR 
(95% CI)
1.97 (1.43–2.72) 1.85 (1.22–2.80) 1.89 (1.35–2.65) 2.01 (1.30–3.11) 0.72 (0.46–1.13) 0.91 (0.49–1.69)
OR indicates odds ratio.
*Models were adjusted for age, history of atrial fibrillation, history of peripheral artery disease, collateral score, serum glucose level, history of diabetes mellitus, 
arterial blood pressure, international normalized ratio (INR>1.7), time from onset to computed tomography, previous stroke, and novel anticoagulants use.
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was used. The association between thrombus migration and 
a lower chance of successful reperfusion was also previously 
reported.13,26
The histological composition of a thrombus might influ-
ence the dynamics it exhibits. Red blood cell-rich thrombi 
have been reported to be more frequent in patients with 
thrombus migration.27 This type of thrombus is more com-
mon in patients with large-vessel atherosclerosis, which may 
explain the increased rate of cervical carotid occlusion and 
the lower incidence of atrial fibrillation in our patients with 
thrombus migration and resolution.28 These patients also had 
a higher rate of multiple intracranial occlusions on first digital 
subtraction angiography before EVT, potentially caused by 
thrombus fragmentation or multiple emboli, another finding 
that points to the influence of thrombus composition, and that 
tends to be more common in red blood cell-rich thrombi.29 
Thrombus fragmentation has also been associated with IVT 
administration before EVT.16 The higher frequency of stent 
treatment and balloon angioplasty may also cause hemody-
namic changes that leads to thrombus migration and resolu-
tion. The smaller thrombus burden in patients with thrombus 
resolution indicates that thrombus volume might influence 
thrombus dynamics. However, the smaller burden in patients 
with thrombus growth may be better explained by selection 
bias, since the thrombus growth group did not include patients 
with CTA ICA occlusions.
The better functional outcome after thrombus migration 
could have several causes. First, the most common changes 
in thrombus location were ICA to M1 and M1 to M2. This 
may allow flow through the lenticulostriate arteries and circle 
of Willis, filling the affected territory via collaterals, leading 
to better functional outcome.30 Second, the higher incidence 
of distal occlusions is also associated with smaller ischemic 
core and better functional outcome.31,32 Because of our defini-
tions, the thrombus growth group did not include ICA occlu-
sions on CTA, whereas almost one quarter of patients on the 
stable group had such ICA occlusions. This may explain why 
there was also a trend towards better functional outcome on 
patients with thrombus growth and why this association was 
lost when only M1 initial target occlusion was included on 
both groups. As expected, thrombus resolution was associated 
with the best functional outcomes, but statistical significance 
was only reached on the M1 initial target occlusion analyses, 
probably because its effect of early reperfusion compared with 
no reperfusion is relatively greater than in distal occlusions 
such as M2.
Our findings reveal a thrombus migration paradox—an 
improvement in functional outcome despite worse reperfusion 
Table 5. Ordinal Logistic Regression Models Assessing the Associations of 
Thrombus Dynamics With Functional Outcome
Outcome
ICA, M1, and M2 CTA 
Occlusion M1 CTA Occlusion
modified Rankin Scale
Model Univariate Multivariable* Univariate Multivariable*
Stable 
thrombus
1.00 [Reference]
Thrombus 
resolution, 
OR (CI)
1.74 
(0.98–3.10)
1.41 
(0.71–2.76)
2.23 
(0.98–5.11)
2.23 
(0.93–5.37)
Thrombus 
migration, 
OR (CI)
1.28 
(1.02–1.61)
1.21 
(0.93–1.58)
1.57 
(1.12–2.19)
1.49 
(1.02–2.17)
Thrombus 
growth, 
OR (CI)
1.21 
(0.82–1.76)
1.18 
(0.77–1.81)
0.91 
(0.51–1.66)
0.92 
(0.47–1.80)
CTA indicates computed tomography angiography; ICA, internal carotid 
artery; and OR, odds ratio.
*Models were adjusted for age, National Institutes of Health Stroke Scale, 
prestroke modified Rankin Scale, onset to groin time, previous atrial fibrillation, 
symptomatic cervical carotid obstruction on CTA, collateral score and 
administration of intravenous thrombolytics.
Table 6. Binary Logistic Regression Models Assessing the Associations of Thrombus Dynamics With Reperfusion Status
ICA, M1, and M2 CTA Occlusion M1 CTA Occlusion
Reperfusion 
Status* Successful Reperfusion Complete Reperfusion Successful Reperfusion Complete Reperfusion
Model Univariate Multivariable† Univariate Multivariable† Univariate Multivariable† Univariate Multivariable†
Stable 
thrombus
1.00 [Reference]
Thrombus 
resolution, 
OR (CI)
6.25 
(2.21–17.7)
4.17  
(1.44–12.1)
15.8 
(6.16–40.7)
14.5 
(5.00–42.1)
5.84 
(1.35–25.2)
4.41 
(1.00–19.5)
19.1 
(4.41–82.4)
17.26 
(3.85–77.4)
Thrombus 
migration, 
OR (CI)
0.79 
(0.61–1.03)
0.74 
(0.55–0.99)
0.57 
(0.41–0.77)
0.51 
(0.36–0.73)
0.86 
(0.58–1.27)
0.73 
(0.48–1.13)
0.47 
(0.30–0.75)
0.32 
(0.17–0.57)
Thrombus 
growth, 
OR (CI)
0.99 
(0.65–1.51)
0.93 
(0.58–1.49)
0.96 
(0.62–1.49)
0.87 
(0.52–1.47)
1.43 
(0.74–2.80)
1.77 
(0.84–3.74)
1.15 
(0.61–2.17)
1.45 
(0.73–2.85)
CTA indicates computed tomography angiography; ICA, internal carotid artery; and OR, odds ratio.
*Reperfusion was assessed on digital subtraction angiography using the expanded treatment in cerebral infarction (eTICI) score. Successful reperfusion was defined 
as an eTICI score of 2b, 2c, or 3.17 Complete reperfusion was defined as an eTICI score of 3.
†Models were adjusted for age, National Institutes of Health Stroke Scale, prestroke modified Rankin Scale, onset to groin time, previous atrial fibrillation, symptomatic 
cervical carotid obstruction on CTA, collateral score, and administration of intravenous thrombolytics.
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status. The shift to a more distal thrombus location reflects 
partial recanalization and subsequent distal embolization of 
thrombus fragments, which is more common after IVT.16,26 
Given the smaller size and more tortuous course of the distal 
arterial branches, thrombectomy devices are not only more 
difficult to deliver to distal occlusions but also less likely 
to be effective.4 The increased rate of thrombus inaccessi-
bility explains why mechanical thrombectomy was less fre-
quently performed in thrombus migration patients and also 
why these patients had a lower chance of successful reper-
fusion. Nevertheless, because thrombus migration improved 
functional outcome in this study, one could speculate that the 
benefit of early proximal revascularization in most cases out-
weighs the negative impact of reperfusion failure. However, 
the relationship between the timing and extent of revascular-
ization must also depend on the extent of the final perfusion 
deficit. For example, an eTICI score of 2A in a patient with 
an M2 occlusion could correspond to more preserved tissue 
than an eTICI score of 2B in a patient with an M1 occlu-
sion. Other factors that could influence the association of 
IVT and patient outcome: IVT may help recanalize remaining 
thrombi in the microvasculature or distal branches, but it is 
also more strongly associated with blood-brain barrier break-
down, increasing the risk of symptomatic intracranial hemor-
rhage.33 A potential confounding factor that must be noted is 
that IVT treated patients have a more favorable treatment pro-
file than their non-IVT treated counterparts. Patients treated 
with IVT have fewer comorbidities and present earlier at the 
hospital. While not significant, this trend can be seen in the 
thrombus dynamic subgroups as well, with more atrial fibril-
lation and marginally longer onset to groin times in the stable 
thrombus group. While we adjusted for these confounders, 
their effects might still contribute to the observed association. 
Current clinical trials investigating the value of additional 
IVT in the era of EVT treatment, such as MR CLEAN-NO 
IV (ISRCTN80619088), DIRECT MT (Direct Intra-arterial 
Thrombectomy In order to Revascularize AIS Patients With 
Large Vessel Occlusion Efficiently in Chinese Tertiary 
Hospitals; NCT03469206), and SWIFT DIRECT (Solitaire 
With the Intention for Thrombectomy Plus Intravenous t-PA 
Versus DIRECT Solitaire Stent-Retriever Thrombectomy in 
Acute Anterior Circulation Stroke; NCT03192332), will aid 
to determine whether the chance of early lysis by IVT out-
weighs the potential negative effects of IVT.
The major limitation of our study is the lack of inclusion 
of patients in whom there was sufficient clinical recovery 
before groin puncture to forego EVT in the MR CLEAN 
Registry. This may have resulted in an underestimation of the 
occurrence of thrombus resolution and migration and their 
beneficial effect. Further, apparent differences in thrombus lo-
cation between the initial and the conventional angiography 
target occlusions might also be caused by reduced flow lead-
ing to delayed contrast delivery proximal to the occlusion. 
The reduced flow may simulate a proximal occlusion on CTA, 
the so-called pseudo-occlusions.34,35 Another limitation were 
disagreements between the interventionist and the core lab. 
This was observed on 8 patients from the thrombus resolu-
tion group on which the interventionist performed mechanical 
thrombectomy, and later, the core lab considered that there 
was no residual thrombus. We also did not consider occlusion 
location differences in subsegments of the intracranial ICA 
and between proximal and distal M1 to reduce the effect of 
the inter-observer disagreement. Stroke cause evaluation was 
limited, because TOAST (Trial of ORG 10172 in Acute Stroke 
Treatment) criteria was not available.36
Conclusions
In patients with acute ischemic stroke due to proximal occlu-
sion of the anterior circulation, preinterventional changes in 
thrombus location are common, especially after IVT. In our 
population, thrombus migration was associated with improved 
functional outcome, although there was an association with 
worse reperfusion status at the end of EVT.
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